{"id":227273,"date":"2026-09-02T11:41:27","date_gmt":"2026-09-02T06:11:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=227273"},"modified":"2026-09-02T11:41:28","modified_gmt":"2026-09-02T06:11:28","slug":"is-abbott-india-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-abbott-india-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Abbott India a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"
<\/div>\n

Abbott India share price around Rs 26,135. 20.3% below 52-week high of Rs 32,775. Q1 FY27 revenue Rs 1,814 crore, up 4.3% YoY. PAT Rs 429 crore, up 17.1%. PE 34x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Abbott India’s Q1 FY27 results were strong, with revenue at Rs 1,814 crore and PAT climbing 17% to Rs 429 crore. The stock trades at a PE of 34x against an industry average near 51x, which leaves room for a re-rating if this growth continues. The Abbott India share price near Rs 26,135 reflects that optimism, so investors weighing whether Abbott India is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.<\/p>\n<\/div>\n

The Abbott India share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Abbott India is a pharmaceutical major selling branded generics, nutrition and consumer health products, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 1,814 crore, up 4.3% year on year, while profit after tax came in at Rs 429 crore, up 17.1% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Abbott India share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Abbott India share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n